Nutrients (Mar 2022)

Pilot Double-Blind Randomised Controlled Trial: Effects of Jejunal Nutrition on Postprandial Distress in Diabetic Gastropathy (J4G Trial)

  • Lucianno Carneiro,
  • Jonathan White,
  • Helen Parker,
  • Caroline Hoad,
  • Emily Tucker,
  • Luca Marciani,
  • Penny Gowland,
  • Tasso Gazis,
  • Marjorie Walker,
  • Mark Fox

DOI
https://doi.org/10.3390/nu14071321
Journal volume & issue
Vol. 14, no. 7
p. 1321

Abstract

Read online

Nausea, vomiting and abdominal pain in diabetic patients are often attributed to diabetic gastropathy (DG). Post-pyloric (“jejunal”) enteral nutrition (JN) may improve nutrition and glycaemia in difficult cases. The acute effects of JN on postprandial symptoms and gastric function in DG patients has not been studied. DG patients with moderate to severe symptoms (gastroparesis cardinal symptom index (GCSI) > 27), diabetic controls without symptoms (DC; GCSI p p p < 0.05). JN induced a GI–peptide response in all subjects; however, this was less pronounced in diabetic groups. JN has beneficial effects on DG patients’ symptoms after a meal. The mechanism is not primarily mediated by effects on GE, but appears to involve other aspects of GI function, including visceral sensitivity.

Keywords